CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- FWP Offering Free Writing Prospectus
- S-3MEF Other S-3MEF
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- RW Other RW
- RW Other RW
- DEFA14A Proxy Proxy Materials
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
Page 5 of 7 · 127 filings